BOAA
RMD icon

Bank of Ann Arbor’s ResMed RMD Stock Holding History

Bank of Ann Arbor’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$11.1K Buy
+50
New +$10.9K ﹤0.01% 392

Other funds holding RMD

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 38.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $127B AUM 33.25% 1-Year Est. Return

Bank of Ann Arbor's RMD Position: Q3 2026 in Review

Bank of Ann Arbor opened a new position in ResMed (RMD) in Q3 2026: 50 shares worth $11.1K. The stake represents ﹤0.01% of the portfolio and ranks #392 among its holdings.

741 funds tracked by Wall St. Rank hold RMD as of Q3 2026.

  • Bank of Ann Arbor held 50 shares of ResMed worth $11.1K as of Q3 2026.
  • ResMed was a new Bank of Ann Arbor position in Q3 2026.
  • ResMed made up ﹤0.01% of Bank of Ann Arbor's portfolio in Q3 2026, its #392 holding.
  • 741 funds tracked by Wall St. Rank held ResMed as of Q3 2026.

Based on Bank of Ann Arbor's 13F filing for Q3 2026, filed 13 Nov 2026.